S. Connors

发表

Exercise and Arrhythmic Risk in TMEM43 p.S358L Arrhythmogenic Right Ventricular Cardiomyopathy.

P. Parfrey, F. Paulin, K. Hodgkinson, 2020, Heart rhythm.

Cardiac Resynchronization Therapy With a Quadripolar Electrode Lead Decreases Complications at 6 Months: Results of the MORE-CRT Randomized Trial.

G. Boriani, C. Leclercq, S. Connors, 2016, JACC. Clinical electrophysiology.

Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene.

Sean Connors, Patrick S Parfrey, Barry Gallagher, 2008, American journal of human genetics.

Left Atrial Vein Pacing:

S. Connors, D. Birnie, Martin S. Green, 2004, Pacing and clinical electrophysiology : PACE.

Insight into the mechanism of failure of the Riata lead under advisory.

J. Healey, A. Krahn, R. Yee, 2015, Heart rhythm.

Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper.

J. Healey, R. Brugada, A. Krahn, 2011, The Canadian journal of cardiology.

Snapshot of adult invasive cardiac electrophysiology in Canada: results of the web-based registry

J. Healey, C. Morillo, A. Verma, 2014, Journal of Interventional Cardiac Electrophysiology.

Regional differences in aortic valve replacements: Atlantic Canadian experience.

J. Légaré, Ansar Hassan, S. Connors, 2018, Canadian journal of surgery. Journal canadien de chirurgie.

Pharmacological and nonpharmacological methods for rate control.

S. Connors, P. Dorian, 2005, The Canadian journal of cardiology.

The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleus.

D. Judge, J. Mogensen, T. Šarić, 2015, European heart journal.

Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy

P. Parfrey, K. Hodgkinson, S. Stuckless, 2016, Circulation. Arrhythmia and electrophysiology.

The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43

A. Bassett, P. Parfrey, K. Hodgkinson, 2013, Clinical genetics.

Do Biologics Protect Patients With Psoriasis From Myocardial Infarction? A Retrospective Cohort

S. Connors, D. MacDonald, W. Gulliver, 2016, Journal of cutaneous medicine and surgery.

Management of supraventricular tachycardia in the emergency department.

S. Connors, P. Dorian, 1997, The Canadian journal of cardiology.

Primary Cardiac T Cell Lymphoma Mimicking ST-Elevation Myocardial Infarction

S. Connors, C. Adams, A. Pirzada, 2017, Cardiology.

Complications Associated With Revision of Sprint Fidelis Leads: Report From the Canadian Heart Rhythm Society Device Advisory Committee

J. Healey, A. Verma, A. Krahn, 2010, Circulation.

Translation of research discoveries to clinical care in arrhythmogenic right ventricular cardiomyopathy in Newfoundland and Labrador: Lessons for health policy in genetic disease

P. Parfrey, E. Dicks, K. Hodgkinson, 2009, Genetics in Medicine.

A novel electrocardiographic phenotype identifies a new clinical form of autosomal dominant arrhythmogenic right ventricular cardiomyopathy

S. Connors, W. McKenna, K. Hodkinson, 2000 .

Bundle Branch Reentrant Ventricular Tachycardia : Novel Genetic Mechanisms in a Life-Threatening Arrhythmia

P. Kwok, V. Vedantham, J. Olgin, 2016 .

The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5).

A. Bassett, P. Parfrey, E. Dicks, 2005, Journal of the American College of Cardiology.

Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and Canada.

P. Elliott, P. Syrris, K. Hodgkinson, 2013, European heart journal.

Radiofrequency ablation of atrial tachycardia originating from the triangle of Koch.

S. Connors, M. Green, A. Tang, 2000, Canadian Journal of Cardiology.

Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention.

A. Skanes, A. Krahn, S. Connors, 2016, The Canadian journal of cardiology.

2004 Canadian Cardiovascular Society Consensus Conference: Atrial Fibrillation.

S. Connolly, A. Skanes, F. Marchlinski, 2005, The Canadian journal of cardiology.

The Canadian experience with Durata and Riata ST Optim defibrillator leads: a report from the Canadian Heart Rhythm Society Device Committee.

J. Healey, A. Krahn, R. Yee, 2013, Heart rhythm.

Failure rate of the Riata lead under advisory: a report from the CHRS Device Committee.

J. Healey, A. Verma, A. Krahn, 2013, Heart rhythm.

Formation of a national network for rapid response to device and lead advisories: The Canadian Heart Rhythm Society Device Advisory Committee.

J. Healey, A. Verma, A. Krahn, 2009, The Canadian journal of cardiology.

Utilization of a national network for rapid response to the Medtronic Fidelis lead advisory: the Canadian Heart Rhythm Society Device Advisory Committee.

J. Healey, A. Verma, A. Krahn, 2009, Heart rhythm.

Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee.

J. Healey, A. Verma, A. Krahn, 2008, Heart rhythm.

Assessment of Resynchronization Therapy on Functional Status and Quality of Life in Patients Requiring an Implantable Defibrillator

S. Connolly, M. Gardner, S. Connors, 2009, Pacing and clinical electrophysiology : PACE.

Cardiac arrest in a mother and daughter and the identification of a novel RYR2 variant, predisposing to low penetrant catecholaminergic polymorphic ventricular tachycardia in a four‐generation Canadian family

B. Fernandez, F. van Petegem, K. Hodgkinson, 2020, Molecular genetics & genomic medicine.

An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia

Rahul C. Deo, J. Healey, C. January, 2020, Circulation.

SEX-INFLUENCED MORTALITY IN THREE WELL-ASCERTAINED FAMILIES WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA CAUSED BY A RYR2 P.R420W MUTATION: THE POWER OF EXTENDED FAMILY HISTORY

K. Hodgkinson, S. Stuckless, T. Young, 2017 .

Psychological Distress and Quality of Life in Participants Undergoing Genetic Testing for Arrhythmogenic Right Ventricular Cardiomyopathy Caused by TMEM43 p.S358L: Is It Time to Offer Population-Based Genetic Screening?

Hensley H. Mariathas, K. Hodgkinson, T. Young, 2021, Public Health Genomics.

J. Healey, R. Brugada, A. Krahn, 2011, The Canadian journal of cardiology.

Cardiac Resynchronization Therapy With a Quadripolar Electrode Lead Decreases Complications at 6 Months Results of the MORE-CRT Randomized Trial

G. Boriani, C. Leclercq, S. Connors, 2022 .

Initial clinical manifestations of Arrythmogenic right ventricular cardiomyopathy (ARVC).

A. Bassett, P. Parfrey, E. Dicks, 2000 .

Bundle Branch Re-Entrant Ventricular Tachycardia: Novel Genetic Mechanisms in a Life-Threatening Arrhythmia.

Rahul C. Deo, P. Kwok, J. Olgin, 2017, JACC. Clinical electrophysiology.